Bullish ForecastMarkets have rallied for the first month(s) of each of the last 5 years. It is my guess that this year will not be different and will play right into the bio tech bull season which runs from now into April. CXR starts this season oversold from assumed and stated fundamentals. Now it is up to management to execute and communicate that earnings goals are on track or exceeded and debt is being paid down. IMO, This is set up for a 50-100% SP increase by April 2016.